173 related articles for article (PubMed ID: 16583845)
1. [Vagina cancer in a young woman exposed to diethylstilbestrol: case report and literature review].
Novoa Vargas A; Grados García C; Bustillos de Cima R; Malagón Millán B
Ginecol Obstet Mex; 2005 Dec; 73(12):666-73. PubMed ID: 16583845
[TBL] [Abstract][Full Text] [Related]
2. Diethylstilbestrol (DES)-induced clear cell adenocarcinoma of the vagina metastasizing to the brain.
Lin LM; Sciubba DM; Gallia GL; Sosnowski J; Weingart JD
Gynecol Oncol; 2007 Apr; 105(1):273-6. PubMed ID: 17292458
[TBL] [Abstract][Full Text] [Related]
3. [Pulmonary metastases from a hormone-induced clear cell adenocarcinoma of the vagina].
Nesme P; Bayle JY; Pérol M; Mathevet P; Vitrey D; Guérin JC
Rev Mal Respir; 1993; 10(6):560-2. PubMed ID: 8122025
[TBL] [Abstract][Full Text] [Related]
4. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
Blythe JG; Michael H; Hodel KA
J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
[TBL] [Abstract][Full Text] [Related]
5. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma.
Waggoner SE; Mittendorf R; Biney N; Anderson D; Herbst AL
Gynecol Oncol; 1994 Nov; 55(2):238-44. PubMed ID: 7959291
[TBL] [Abstract][Full Text] [Related]
6. Concurrent primaries of vaginal clear cell adenocarcinoma and endometrial adenocarcinoma in a 39-year old woman with in utero diethylstilbestrol exposure.
Keller C; Nanda R; Shannon RL; Amit A; Kaplan AL
Int J Gynecol Cancer; 2001; 11(3):247-50. PubMed ID: 11437935
[TBL] [Abstract][Full Text] [Related]
7. Clear cell adenocarcinoma of the vagina in a young female, treated by combination chemotherapy (local and systemic chemotherapy), complicated with chromosomal abnormality.
Tanaka H; Tabata T; Yanase H; Nishiyama M; Yamawaki T; Taniguchi H; Toyoda N
Gynecol Oncol; 1994 Nov; 55(2):259-64. PubMed ID: 7959294
[TBL] [Abstract][Full Text] [Related]
8. [Pregnancy after transposition and repositioning of the ovaries in a patient with clear-cell adenocarcinoma].
Gerbaulet A; Escaillet B; Beral Y; Fourika F; Yovo G; Houze D; Schneider B; Klopfenstein D
Rev Fr Gynecol Obstet; 1995 Dec; 90(12):534-8. PubMed ID: 8677407
[TBL] [Abstract][Full Text] [Related]
9. A young woman with clear cell adenocarcinoma of the uterine cervix.
Seki H; Takada T; Sodemoto T; Hoshino H; Saitoh K; Uekusa T
Int J Clin Oncol; 2003 Dec; 8(6):399-404. PubMed ID: 14663645
[TBL] [Abstract][Full Text] [Related]
10. Development of clear cell adenocarcinoma in DES-exposed offspring under observation.
Kaufman RH; Korhonen MO; Strama T; Adam E; Kaplan A
Obstet Gynecol; 1982 Jun; 59(6 Suppl):68S-72S. PubMed ID: 7088431
[TBL] [Abstract][Full Text] [Related]
11. Primary non-clear-cell adenocarcinoma of the vagina in a diethylstilbestrol exposed woman.
Patel SA; Sunde J
Mil Med; 2014 Apr; 179(4):e461-2. PubMed ID: 24690973
[TBL] [Abstract][Full Text] [Related]
12. Endobronchial clear cell adenocarcinoma occurring in a patient 15 years after treatment for DES-associated vaginal clear cell adenocarcinoma.
Hall WB; Detterbeck FC; Livasy CA; Fowler WC
Gynecol Oncol; 2004 Jun; 93(3):708-10. PubMed ID: 15196869
[TBL] [Abstract][Full Text] [Related]
13. Development of DES-associated clear-cell carcinoma: the importance of regular screening.
Anderson B; Watring WG; Edinger DD; Small EC; Netland AT; Safaii H
Obstet Gynecol; 1979 Mar; 53(3):293-9. PubMed ID: 424100
[TBL] [Abstract][Full Text] [Related]
14. Clear-cell adenocarcinoma of the lower genital tract: Memorial Hospital 1974-1984.
Jones WB; Koulos JP; Saigo PE; Lewis JL
Obstet Gynecol; 1987 Oct; 70(4):573-7. PubMed ID: 3627626
[TBL] [Abstract][Full Text] [Related]
15. The long-term effects of in utero exposures--the DES story.
Goodman A; Schorge J; Greene MF
N Engl J Med; 2011 Jun; 364(22):2083-4. PubMed ID: 21506735
[No Abstract] [Full Text] [Related]
16. Colposcopic findings and intraepithelial neoplasia in diethylstilbestrol-exposed offspring. The Dutch experience.
Helmerhorst TJ; Wijnen HJ; Kenemans P; Tjioe GS; Dijkhuizen HH; Calame JJ; Stolk HG
Am J Obstet Gynecol; 1989 Nov; 161(5):1191-4. PubMed ID: 2589438
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of Patients with Clear-Cell Adenocarcinoma of the Vagina and Cervix.
Huo D; Anderson D; Herbst AL
N Engl J Med; 2018 May; 378(18):1746-1748. PubMed ID: 29719188
[No Abstract] [Full Text] [Related]
18. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
[TBL] [Abstract][Full Text] [Related]
19. [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic].
van Dijck JA; Doorduijn Y; Bulten JH; Verloop J; Massuger LF; Kiemeney BA
Ned Tijdschr Geneeskd; 2009; 153():A366. PubMed ID: 19857300
[TBL] [Abstract][Full Text] [Related]
20. Preservation of reproductive potential in diethylstilbestrol-related vaginal adenocarcinoma.
Hudson CN; Crandon AJ; Baird PJ; Willcocks D
Am J Obstet Gynecol; 1983 Feb; 145(3):375-77. PubMed ID: 6824026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
